Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Figs Inc Cl A (NY: FIGS )

4.809 +0.089 (+1.89%)
Streaming Delayed Price Updated: 12:56 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Figs Inc Cl A

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
What 8 Analyst Ratings Have To Say About FIGS
Via Benzinga
Meta Platforms To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Tuesday
Morgan Stanley boosted the price target for HubSpot, Inc. (NYSE: HUBS) from $447 to $466. Morgan Stanley analyst Keith Weiss maintained an Overweight rating. HubSpot shares fell 1.9% to close at... 
Via Benzinga
Figs Stock Is Down Nearly 90% From Its High. Time to Buy?
The medical apparel maker faces tough near-term headwinds. 
Via The Motley Fool
The Good News From Salesforce
And we talk about people pulling back on spending on all those things that probably seemed essential in the earlier days of the pandemic. 
Via The Motley Fool
$5M Bet On FIGS? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed mixed on Wednesday, there were a few notable insider trades. 
Via Benzinga
FIGS, Inc. (NYSE:FIGS) Long Term Investor Alert: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 03/03/2023 -- An investigation on behalf of current long-term investors in shares of FIGS, Inc. (NYSE:FIGS) concerning potential breaches of fiduciary duties by certain... 
Via SBWire
Analyst Ratings for FIGS
Via Benzinga
Figs (FIGS) Q4 2022 Earnings Call Transcript
FIGS earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Could Figs Stock Hit $20 in 2023?
Reaching this lofty price target would certainly please investors. 
Via The Motley Fool
FIGS Announces Participation in the KeyBanc Emerging Technology Summit
From FIGS, Inc.
Via Business Wire
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Why Figs Stock Was Up This Week
Easing inflation could be a big catalyst in 2023. 
Via The Motley Fool
Expert Ratings for FIGS
Via Benzinga
Down 75.6% in 2022, Is Figs Stock a Buy for 2023?
The stylish healthcare apparel company has challenges to overcome. 
Via The Motley Fool
Why Figs Stock Lost 76% in 2022
Slowing revenue growth torched shares of the healthcare apparel company. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
FIGS Announces Participation in the Raymond James Institutional Investors Conference
From FIGS, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Shares of Figs Inc. Are Trading Lower On Earnings Beat: What's Going On?
Shares of Figs Inc (NYSE: FIGS) are trading lower into Tuesday’s after-market session following an earnings beat. Here’s what investors need to know. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
FIGS Releases Fourth Quarter and Full Year 2022 Financial Results
From FIGS, Inc.
Via Business Wire
SPI’s Litigation Against FIGS Is Over
From FIGS, Inc.
Via Business Wire
BAX: A “Hospital Stock” To Avoid
Baxter International's shares are down nearly 50% over the past three years and have underperformed the broader healthcare industry. 
Via Talk Markets
Retail Industry Veteran Steve Berube Joins FIGS as Chief Operating Officer and Devon Duff Gago Is Appointed Chief Business Development Officer
From FIGS, Inc.
Via Business Wire
FIGS Announces Date of Fourth Quarter and Full Year 2022 Earnings Release, Conference Call and Webcast
From FIGS, Inc.
Via Business Wire
2 Supercharged Stocks to Buy In 2023 That Could Double Your Money
Don't let these stocks pass you by. 
Via The Motley Fool
FIGS ALERT: Bragar Eagel & Squire, P.C. is Investigating FIGS, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
2 High-Growth Stocks That Are on Sale Now
The market is not giving these rising stars the credit they deserve. 
Via The Motley Fool
These 2 Stocks Are All-Stars In the Making
Down 46% and 73% over the last year, these companies look poised to rebound as they eye international sales. 
Via The Motley Fool
Skechers Not Nike Is The Sneaker Stock to Own for 2023
A tech-driven focus on comfort, omnichannel growth, international expansion and a low P/E are all good reasons to step into Skechers stock. 
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.